Description
TG-Ark is a high-potency injectable antibiotic formulated with Tigecycline 50mg Injection IP, designed to treat severe and complicated bacterial infections. As a next-generation glycylcycline antibiotic, tigecycline provides extended coverage against a wide range of pathogens, including multidrug-resistant organisms. This makes TG-Ark a reliable choice in hospital and critical care settings.
The composition Tigecycline 50 mg injection works by inhibiting bacterial protein synthesis, effectively stopping infection growth. It is commonly used when standard antibiotics fail, making it highly valuable in modern treatment protocols.
Key Highlights
- Broad-spectrum glycylcycline antibiotic
- Effective against resistant bacterial strains
- Suitable for hospital and ICU use
- Supplied as a sterile 50 mg vial
Uses of Tigecycline Injection
- Complicated intra-abdominal infections
- Skin and soft tissue infections
- Resistant bacterial infections
- Secondary infections in critical patients
Product Details
- Brand Name: TG-Ark
- Composition: Tigecycline 50mg Injection IP
- Pack Size: 1*50MG
- Style: Vial
- Price: ₹2780
TG-Ark is widely preferred for its proven efficacy and safety when administered under medical supervision. It plays a vital role in combating antimicrobial resistance.
Conclusion:
TG-Ark (Tigecycline 50mg Injection) is a dependable, hospital-grade antibiotic offering strong protection against complex infections, ensuring better clinical outcomes.
